A possible role for human papillomaviruses in head and neck cancer

Cancer and Metastasis Reviews

Volumn 15, Issue 1, 1996, Pages 91-112

  Steinberg, Bettie M ^a   DiLorenzo, Teresa P ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

papillomavirus; respiratory papillomas; tonsillar cancer; tumor suppressor genes; verrucous cancer

Indexed keywords

HEAD AND NECK CANCER; HUMAN; MOUTH CARCINOMA; PAPILLOMA VIRUS; PAPILLOMATOSIS; PRIORITY JOURNAL; REVIEW; TONGUE CARCINOMA; TONSIL CARCINOMA; TUMOR SUPPRESSOR GENE;

HEAD AND NECK NEOPLASMS; HUMANS; PAPILLOMAVIRIDAE;

EID: 0029934432     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00049489     Document Type: Review

References (178)

1. Pfister H: Papillomaviruses and Human Cancer. CRC Press, Boca Raton, 1990, pp 1-9
2. Chiang CM, Ustav M, Stenlund A, Ho TF, Broker TR, Chow LT: Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc Natl Acad Sci USA 89: 5799-5803, 1992
3. Remm M, Brain R, Jenkins JR: The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. Nucleic Acids Res 20: 6015-6021, 1992
4. Del Vecchio AM, Romanczuk H, Howley PM, Baker CC: Transient replication of human papillomavirus DNAs. J Virol 66: 5949-5458, 1992
5. Kuo SR, Liu JS, Broker TR, Chow LT: Cell-free re-plication of the human papillomavirus DNA with homologous viral E1 and E2 proteins and human cell extracts. J Biol Chem 269: 24058-24065, 1994
6. McBride AA, Romanczuk H, Howley PM: The papillomavirus E2 regulatory proteins. J Biol Chem 266:18411-18414, 1991
7. Chin MT, Hirochika R, Hirochika H, Broker TR, Chow LT: Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: Functional and biochemical studies. J Virol 62: 2994-3002, 1988
8. Tan SH, Gloss B, Bernard HU: During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Spl from a proximal promoter element. Nucleic Acids Res 20: 251-256, 1992
9. Woodworth CD, Bowden PE, Doniger J, Pirisi L, Barnes W, Lancaster WD, Di Paolo JA: Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18 DNA. Cancer Res 48:4620-4628, 1988
10. Barbosa MS, Schlegel R: The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 4: 1529-1532, 1989
11. Straight SW, Hinkle PM, Jewers RJ, McCance DJ: The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J Virol 67: 4521-4532, 1993
12. Brandsma JL: Animal models of human-papillomavirus-associated oncogenesis. Intervirology 37: 189-200, 1994
13. Doorbar J, Ely S, Sterling J, McClean C, Crawford L: Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature 352: 824-827, 1991
14. Chow LT, Broker TR: Papillomavirus DNA replication. Intervirology 37: 150-158, 1994
15. Fuchs PG, Pfister H: Transcription of papillomavirus genomes. Intervirology 37: 159-167, 1994
16. Chow LT, Nasseri M, Wolinsky SM, Broker TR: Human papillomavirus types 6 and 11 mRNAs from genital condylomala acuminata. J Virol 61: 2581-2588, 1987
17. Smotkin D, Prokoph H, Wettstein FO: Oncogenic and non-oncogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J Virol 63: 1441-1447, 1989
18. Ward P, Mounts P: Heterogeneity in mRNA of human papillomavirus type-6 subtypes in respiratory tract lesions. Virology 168: 1-12, 1989
19. Nasseri M, Hirochika R, Broker TR, Chow LT: A human papillomavirus type 11 transcript encoding an E1-E4 protein. Virology 159: 433-439, 1987
20. Doorbar J, Parton A, Hartley K, Banks L, Crook T, Stanley M, Crawford L: Detection of novel splicing patterns in a HPV 16-containing keratinocyte cell line. Virology 178: 254-262, 1990
21. Rotenberg MO, Chow LT, Broker TR: Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction. Virology 172: 489-497, 1989
22. Miller SJ, Sun TT, Lavker RM: Hair follicles, stem cells, and skin cancer. J Invest Dermatol 100: 288S-294S, 1993
23. Stanley MA: Virus-keratinocyte interactions in the infectious cycle. In: Stern PL, Stanley M (eds) Human Papillomaviruses and Cervical Cancer. Biology and Immunology, Oxford University Press, Oxford, 1994, pp 116-145
24. Zhou J, Sun XY, Stenzel DJ, Frazer IH: Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 185: 251-257, 1991
25. Steinberg BM, Auborn KJ, Brandsma JL, Taichman LB: Tissue site-specific enhancer function of the upstream regulatory region of human papillomavirus type 11 in cultured keratinocytes. J Virol 63: 957-960, 1989
26. Maran A, Amelia CA, DiLorenzo TP, Auborn KJ, Taichman LB, Steinberg BM: Human papillomarivus type 11 transcripts are present at low abundance in latently infected respiratory tissues. Virology 212: 285-294, 1995
27. Meyers C, Harry J, Lin YL, Wettstein FO: Identification of three transforming proteins encoded by cottontail rabbit papillomavirus. J Virol 66: 1655-1664, 1992
28. Brandsma JL, Yang ZH, Barthold SW, Johnson EA: Use of a rapid, efficient inoculation method to induce papillomas by cottontail rabbit papillomavirus DNA shows that the E7 gene is required. Proc Natl Acad Sci USA 88: 4816-4820, 1991
29. Stoler MH, Whitbeck A, Wolinsky SM, Broker TR, Chow LT, Howett MK, Kreider JW: Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice. J Virol 64: 3310-3318, 1990
30. Steinberg BM, Topp WC, Schneider PS, Abramson AL: Laryngeal papillomavirus infection during clinical remission. N Engl J Med 308: 1261-1264, 1983
31. Ferenczy A, Mitao M, Nagai N, Silverstein SJ, Crum CP: Latent papillomavirus and recurring genital warts. N Engl J Med 313: 784-788, 1985
32. Toon PG, Arrand JR, Wilson LP, Sharp DS: Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia. Br Med J Clin Res Ed 293: 1261-1264, 1986
33. Amtmann E, Volm M, Wayss K: Tumour induction in the rodent Mastomys natalensis by activation of endogenous papillomavirus genomes. Nature 308: 291-292, 1984
34. Siegsmund M, Wayss K, Amtmann E: Activation of latent papillomavirus genomes by chronic mechanical irritation. J Gen Virol 72: 2787-2789, 1991
35. Amella CA, Lofgren LA, Ronn AM, Nouri M, Shikowitz MJ, Steinberg BM: Latent infection induced with cottontail rabbit papillomavirus: A model for human papillomavirus latency. Am J Pathol 144: 1167-1171, 1994
36. Campo MS, Jarrett WFH, O'Neil W, Barron RJ: Latent papillomavirus infection in cattle. Res Vet Sci 56: 151-157, 1994
37. Benton C, Shahidullah H, Hunter JAA: Human papillomavirus in the immunosuppressed. Papillomavirus Rep 3: 23-26, 1992
38. Haglund S, Lundquist PG, Cantell K, Strander H: Interferon therapy in juvenile laryngeal papillomatosis. Arch Otolaryngol 107: 327-332, 1981
39. Auborn KJ, Steinberg BM: Therapy of papillomavirus-induced lesions. In: Pfister H (ed.) Papillomavirus and Human Cancer, CRC Press, Boca Raton, 1990, pp 203-223
40. Abramson AL, Steinberg BM, Winkler B: Laryngeal papillomatosis: clinical, histopathologic and molecular studies. Laryngoscope 97: 678-685, 1987
41. Steinberg BM, Meade R, Kalinowski S, Abramson AL: Abnormal differentiation of human papillomavirus-induced laryngeal papillomas. Arch Otolaryngol Head Neck Surg 116: 1167-1171, 1990
42. Iftner T, Oft M, Bohm S, Wilczynski SP Pfister H: Transcription of the E6 and E7 genes of human papillomavirus type 6 in anogenital condylomata is restricted to undifferentiated cell layers of the epithelium. J Virol 66:4639-4646, 1992
43. Stoler MH, Wolinsky SM, Whitbeck A, Broker TR, Chow LT: Differentiation-linked human papillomavirus type 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 172: 331-340, 1989
44. Durst M, Glitz D, Schneider A, zur Hausen H: Human papillomavirus type 16 (HPV16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hyhridization. Virology 189: 132-140, 1992
45. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR: Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 23: 117-128, 1992
46. Lack EE, Jenson AB, Smith HG, Healy GB, Pass F, Vawter GF: Immunoperoxidase localization of human papillomavirus in laryngeal papillomas. Intervirology 14: 148-154, 1980
47. Chang F, Syrjanen S, Kellokoski J, Syrjanen K: Human papillomavirus (HPV) infection and their associations with oral disease. J Oral Pathol Med 20: 305-317, 1991
48. Loning T, Reichart P, Staquet MJ, Becker J, Thivolet J: Occurrence of papillomavirus structural antigens in oral papillomas and leukoplakias. J Oral Pathol 13: 155-165, 1984
49. Ward KA, Napier SS, Winter PC, Maw RD, Dinsmore WW: Detection of human papillomavirus DNA sequences in oral squamous cell papillomas by the polymerase chain reaction. Oral Surg Oral Med Oral Path Oral Radiol 80: 63-66, 1995
50. Pfister H, Hettich I, Runne U, Gissmann L, Chilf GN: Characterization of human papillomavirus type 13 from focal epithelial hyperplasia Heck lesions. J Virol 47: 363-366, 1983
51. Beaudenon S, Practorius F, Kremsdorf D, Lutzner M, Worsaac N, Pehau-Arnaudet G, Orth G: A new type of human papillomavirus associated with oral focal epithelial hyperplasia. J Invest Dermatol 88: 130-135, 1987
52. Sarkar FH, Visscher DW, Kintanar EB, Zarbo RJ, Crissman JD: Sinonasal Schneiderian papillomas: human papillomavirus typing by polymerase chain reaction. Mod Pathol 5: 329-332, 1992
53. Brandsma J, Abramson A, Sciubba J, Shah K, Barrezueta N, Galli R: Papillomavirus infection of the nose. In: Steinberg BM, Brandsma JL, Taichman LB (eds) Cancer Cells 5: Papillomaviruses. Cold Spring Harbor Press, Cold Spring Harbor, 1987, pp 301-308
54. Judd R, Zaki SR, Coffield LM, Evatt BL: Sinonasal papillomas and human papillomavirus: human papillomavirus 11 detected in fungiform Schneiderian papillomas by in situ hybridization and the polymerase chain reaction. Hum Pathol 22: 550-556, 1991
55. Buchwald C, Franzmann M-B, Jacobsen CiK, Lindeberg H: Human papillomavirus (HPV) in sinonasal papillomas: a study of 78 cases using in situ hybridization and polymerase chain reaction. Laryngoscope 105: 66-71, 1995
56. Fu YS, Hoover L, Franklin M, Cheng L, Stoler MH: Human papillomavirus identified by nucleic acid hybridization in concomitant nasal and genital papillomas. Laryngoscope 102: 1014-1019, 1992
57. Beck JC, MeClatchey KD, Lesperance MM, Esclamado RM, Carey TL, Bradford CR: Presence of human papillomavirus predicts recurrence of inverted papilloma. Otolaryngol Head Neck Surg 113: 49-55, 1995
58. Wu T-C, Trujillo JM, Kashima HK, Mounts P: Association of human papillomavirus with nasal neoplasia. Lancet 341: 522-524, 1993
59. Steinberg BM: Laryngeal papillomas: Clinical aspects and in vitro studies. In: Salzman NP, Howley PM (eds) The Papovaviridae. Vol 2. The Papillomaviruses. Plenum Press, New York, 1987, pp 265-292
60. Mounts P, Shaw KV, Kashima H: Viral etiology of juvenile and adult onset squamous papilloma of the larynx. Proc Natl Acad Sci USA 79: 5425-5429, 1982
61. Rihkanen H, Aatonen L-M, Syrjanen SM: Human papillomavirus in laryngeal papillomas and in adjacent normal epithelium. Clin Otolaryngol 18: 470-474, 1993
62. Pignatari S, Smith EM, Gray SD, Shive C, Turek LP: Detection of human papillomavirus infection in diseased and non-diseased sites of the respiratory tract in recurrent respiratory papillomatosis patients by DNA hybridization. Ann Otol Rhinol Laryngol 101: 408-412, 1992
63. De Villiers E-M, Gissmann L, zur Hausen H: Molecular cloning of viral DNA from human genital warts. J Virol 40: 932-935, 1981
64. Gissmann L, Diehl V, Schultz-Coulon H-J, zur Hausen H: Molecular cloning and characterization of human papillomavirus DNA derived from a laryngeal papilloma. J Virol 44: 393-400, 1982
65. Dickens P, Srivastava G, Loke SL, Larkin S: Human papilloma virus 6, 11, and 16 in laryngeal papillomas. J Pathol 165: 243-246, 1991
66. 2 laser. Ann Otol Rhinol Laryngol 85: 508-516, 1976
67. Lindeberg H, Elbrond O: Laryngeal papillomas: the epidemiology in a Danish subpopulation 1965-1984. Clin Otolaryngol 15: 125-131, 1990
68. Cook TA, Brunschwig JP, Butel JS, Cohn AM, Goepfert H, Rawls WE: Laryngeal papilloma: etiologic and therapeutic considerations. Ann Otol Rhinol Laryngol 82: 649-655, 1973
69. Quick CA, Watts SL, Krzyzek RA, Faras AJ: Relationship between condylomata and laryngeal papillomata. Clinical and molecular virological evidence. Ann Otol Rhinol Laryngol 89: 467-471, 1980
70. Shah K, Kashima H, Polk BF, Shah F, Abbey H, Abramson A: Rarity of cesarean delivery in cases of juvenile onset respiratory papillomatosis. Obstet Gynecol 68: 795-799, 1986
71. Brandsma JL, Abramson AL: Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 115: 621-625, 1989
72. Rikhanen H, Peltomaa J, Syrjanen S: Prevalence of human papillomavirus (HPV) DNA in vocal cords without laryngeal papillomas. Acta Otolaryngol (Stockh) 114: 348-351, 1994
73. Kellokoski J, Syrjanen S, Yliskoski M, Syrjanen K: Dot blot hybridization in detection of human papillomavirus (HPV) infections in the oral cavity of women with genital HPV infections. Oral Microbiol Immunol 7: 19-23, 1992
74. Abramson AL, Shikowitz MJ, Mullooly VM, Steinberg BM, Hyman RB: Variable light dose effect on photodynamic therapy for laryngeal papillomas. Arch Otolaryngol Head Neck Surg 120: 852-855, 1994
75. Lofgren LA, Ronn AM, Abramson AL, Shikowitz MJ, Nouri M, Lee CJ, Batti J, Steinberg BM: Photodynamic therapy using meso-tetra(hydroxyphenyl) chlorin: An animal model. Arch Otolaryngol Head Neck Surg 120: 1355-1362, 1994
76. Altmann A, Jochmus I, Rosl F: Intra- and extracellular control mechanisms of human papillomavirus infection. Intervirology 37: 180-188, 1994
77. Connor ME, Stern PL: Loss of MHC class-I expression in cervical carcinomas. Int J Cancer 46: 1029-1034, 1990
78. Cromme FV, Airey J, Heemels MT, Ploegh HL, Keating PJ, Stern PL, Meijer CJLM, Walboomers JMM: Loss of transporter protein, encoded by the Tap-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J Exp Med 179: 335-340, 1994
79. Bonagura VR, Siegal FP, Abramson AL, Santiago-Schwarz F, O'Reilly ME, Shah K, Drake D, Steinberg BM: Enriched HLA-DQ3 phenotype and decreased class I major histocompatibility complex antigen expression in recurrent respiratory papillomatosis. Clin Diag Lab Immunol 1: 357-360, 1994
80. Wank R, Thomssen C: High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 352: 723-725, 1991
81. Glew SS, Stern PL, Davidson JA, Dyer PA: HLA antigens and cervical carcinoma. Nature 356: 22, 1992
82. Asselineau D, Prunieras M: Reconstruction of 'simplified' skin: control of fabrication. Br J Dermatol 111 (Suppl 27): 219-222, 1984
83. Dollard SC, Wilson JL, Demeter LM, Bonnez W, Reichman RC, Broker TR, Chow LT: Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. Genes Dev 6: 1131-1142, 1992
84. Mendelsohn MG, DiLorenzo TP, Abramson AL, Steinberg BM: Retinoic acid regulates, in vitro, the two normal pathways of differentiation of human laryngeal keratinocytes. In Vitro Cell Dev Biol 27A: 137-141, 1991
85. Reppucci AD, DiLorenzo TP, Abramson AL, Steinberg BM: In vitro modulation of human laryngeal papilloma cell differentiation by retinoic acid. Otolaryngol Head Neck Surg 105: 528-532, 1991
86. DiLorenzo TP, Steinberg BM: Differential regulation of human papillomavirus type 6 and 11 early promoters in cultured cells derived from laryngeal papillomas. J Virol 69: 6865-6872, 1995
87. Vambutas A, DiLorenzo TP, Steinberg BM: Laryngeal papilloma cells have high levels of epidermal growth factor receptor and respond to epidermal growth factor by a decrease in epithelial differentiation. Cancer Res 53: 910-914, 1993
88. Galloway TC, Soper GR, Elsen G: Carcinoma of the larynx after irradiation of papilloma. Arch Otolaryngol 72: 289-294, 1960
89. Majoros M, Devine KD, Parkhill EM: Malignant transformation of benign laryngeal papillomas in children after radiation therapy. Surg Clin North Am 43: 1049-1061, 1963
90. Brach BB, Klein RC, Mathews AJ, Cook EW: Papillomatosis of the respiratory tract: upper airway obstruction and carcinoma. Arch Otolaryngol 104: 413-416, 1978
91. Schnadig VJ, Clark WD, Clegg TJ, Yao CS: Invasive papillomatosis and squamous carcinoma complicating juvenile laryngeal papillomatosis. Arch Otolaryngol Head Neck Surg 112: 966-971, 1986
92. Zarod AP, Rutherford JD, Corbitt G: Malignant progression of laryngeal papilloma associated with human papilloma virus type 6 (HPV 6) DNA. J Clin Pathol 41: 280-283, 1988
93. Byrne JC, Tsao M-S, Fraser RS, Howley PM: Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung. N Engl J Med 317: 873-878, 1987
94. DiLorenzo TP, Tamsen A, Abramson AL, Steinberg BM: Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterized by a partial duplication. J Gen Virol 73: 423-428, 1992
95. Yoder MG, Batsakis JG: Squamous cell carcinoma in solitary laryngeal papilloma. Otolaryngol Head Neck Surg 88: 745-748, 1980
96. Singh B, Ramsaroop R: Clinical features of malignant transformation in benign laryngeal papillomata. J Laryngol Otol 108: 642-648, 1994
97. Kashima H, Wu T-C, Mounts P, Heffner D, Cachay A, Hymns V: Carcinoma ex-papilloma: histologic and virologic studies in whole-organ sections of the larynx. Laryngoscope 98: 619-624, 1988
98. Lindeberg H, Syrjanen S, Karja J, Syrjanen K: Human papillomavirus type 11 DNA in squamous cell carcinomas and pre-existing multiple laryngeal papillomas. Acta Otolaryngol (Stockh) 107: 141-149, 1989
99. Rosen M, Auborn K: Duplication of the upstream regulatory sequences increases the transformation potential of human papillomavirus type 11. Virology 185: 484-487, 1991
100. Brandsma JL, Steinberg BM, Abramson AL, Winkler B: Presence of human papillomavirus type 16 related sequences in verrucous carcinoma of the larynx. Cancer Res 46: 2185-2188, 1986
101. Bryan RL, Bevan IS, Croeker J, Young LS: Detection of HPV 6 and 11 in tumours of the upper respiratory tract using the polymerase chain reaction. Clin Otolaryngol 15: 177-180, 1990
102. Perez-Ayala M, Ruiz-Cabello F, Esteban F, Concha A, Redondo M, Oliva MR, Cabrera T, Garrido T: Presence of HPV 16 sequences in laryngeal carcinomas. Int J Cancer 46: 8-11, 1990
103. Fliss DM, Noble-Topham SE, McLachlin M, Freeman JL, Noyek AM, van Nostrand AWP, Hartwick RW: Laryngeal verrucous carcinoma: A clinicopathologic study and detection of human papillomavirus using polymerase chain reaction. Laryngoscope 104: 146-152, 1994
104. Noble-Topham SE, Fliss DM, Hartwick WJ, McLachlin CM, Freeman JL, Noyek AM, Andrulis IL: Detection and typing of human papillomavirus in verrucous carcinoma of the oral cavity using the polymerase chain reaction. Arch Otolaryngol Head Neck Surg 119: 1299-1304, 1993
105. Adler-Storthz K, Newland JR, Tessin BA, Yeudall WA, Shillitoe EJ: Human papillomavirus type 2 DNA in oral verrucous carcinoma. J Oral Pathol 15: 472-475, 1986
106. Roman A, Fife K: Human papillomaviruses: are we ready to type? Clin Microbiol Rev 2: 166-190, 1989
107. Shibata DK, Arnheim N, Martin WJ: Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med 167: 225-230, 1988
108. Kwok S, Higuchi R: Avoiding false positives with PCR. Nature 339: 237-238, 1989
109. Beyer-Finkler E, Pfister H, Girardi F: Anti-contamination primers to improve specificity of polymerase chain reaction in human papillomavirus screening. Lancet 335: 1289-1290, 1990
110. Morrison EAB, Goldberg GL, Kadish AS, Burk RD: Polymerase chain reaction detection of human papillomavirus: Quantitation may improve clinical utility. J Clin Microbiol 30: 2539-2543, 1992
111. De Villiers E-M, Weidauer H, Otto H, zur Hausen H: Papillomavirus DNA in human tongue carcinomas. Int J Cancer 36: 575-578, 1985
112. Brachman DG, Graves D, Vokes E, Beckett M, Haraf D, Montag A, Dunphy E, Mick R, Yandell D, Weichselbaum RR: Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 52: 4832-4836, 1992
113. Ogura H, Watanahe S, Fukushima K, Masuda Y, Fujiwara T, Yabe Y: Human papillomavirus DNA in squamous cell carcinomas of the respiratory and upper digestive tracts. Jpn J Clin Oncol 23: 221-225, 1993
114. Shindoh M, Sawada Y, Kohgo T, Amemiya A, Fujinaga K: Detection of human papillomavirus DNA sequences in tongue squamons-cell carcinoma utilizing the polymerase chain reaction method. Int J Cancer 50: 167-171, 1992
115. Snijders PJF, Cromme FV, van den Brille AJC, Schrijnemakers HFJ, Snow GB, Meijer CJLM, Walboomers JMM: Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 51: 845-850, 1992
116. Snijders PJF, Steenbergen RDM, Top B, Scott SD, Meijer CJLM, Walboomers JMM: Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus. J Gen Virol 75: 2769-2775, 1994
117. Brandwein M, Zeitlin J, Nuovo GJ, MacConnell P, Bodian C, Urken M, Biller H: HPV detection using 'hot start' polymerase chain reaction in patients with oral cancer: a clinicopathological study ot 64 patients. Mod Pathol 7: 720-727, 1994
118. Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard H-U, Chan S-Y: Human papillomaviruses in 91 oral cancers from Indian betel quid chewers - high prevalence and multiplicity of infections. Int J Cancer 61: 450-454, 1995
119. Chang KW, Chang CS, Lai KS, Chou MJ, Choo KB: High prevalence of human papillomavirus infection and possible association with betel quid chewing and smoking in oral epidermoid carcinomas in Taiwan. J Med Virol 28: 57-61, 1989
120. Thomas SJ, MacLennan R: Slaked lime and betel nut cancer in Papua New Guinea. Lancet 340: 577-578, 1992
121. Syrjanen S, Happonen R-P, Virolainen E, Siivonen L, Syrjanen K: Detection of human papillomavirus (HPV) structural antigens and DNA types in inverted papillomas and squamous cell carcinomas of the nasal cavities and paranasal sinuses. Acta Otolaryngol (Stockh) 104: 334-341, 1987
122. Hording U, Winther HW, Daugaard S, Albeck H: Human papillomavirus types 11 and 16 detected in nasopharyngeal carcinomas by the polymerase chain reaction. Laryngoscope 104: 99-102, 1994
123. Dickens P, Srivastava G, Liu YT: Human papillomavirus 16/18 and nasopharyngeal carcinoma. J Clin Pathol 45: 81-82, 1992
124. Furuta Y, Takasu T, Asai T, Shinohara T, Sawa H, Nagashima K, Inuyama Y: Detection of human papillomavirus DNA in carcinomas of the nasal cavities and paranasal sinuses by polymerase chain reaction. Cancer 69: 353-357, 1992
125. Judd R, Zaki SR, Coffield LM, Evatt BL: Human papillomavirus type 6 detected by the polymerase chain reaction in invasive sinonasal papillary squamous cell carcinoma. Arch Pathol Lab Med 115: 1150-1153, 1991
126. Tyan Y-S, Liu S-T, Ong W-R, Chen M-L, Shu C-H, Chang Y-S: Detection of Epstein-Barr virus and human papillomavirus in head and neck tumors. J Clin Microbiol 31: 53-56, 1993
127. Lawson W, Le Benger J, Som P, Bernard PJ, Biller HF: Inverted papilloma: an analysis of 87 cases. Laryngoscope 99: 1117-1124, 1989
128. MacDonald MR, Le KT, Freeman J, Hui MF, Cheung RK, Dosch H-M: A majority of inverted sinonasal papillomas carries Epstein-Barr virus genomes. Cancer 75: 2307-2312, 1995
129. Salam MA, Rockett J, Morris A: General primer-mediated polymerase chain reaction for simultaneous detection and typing of human papillomavirus DNA in laryngeal squamous cell carcinomas. Clin Otolaryngol 20: 84-88, 1995
130. Hoshikawa T, Nakajima T, Uhara H, Gotoh M, Shimosato Y, Tsutsumi K, Ono I, Ebihara S: Detection of human papillomavirus DNA in laryngeal squamous cell carcinomas by polymerase chain reaction. Laryngoscope 100: 647-650, 1990
131. Nunez DA, Astley SM, Lewis FA, Wells M: Human papilloma viruses: a study of their prevalence in the normal larynx. J Laryngol Otol 108: 319-320, 1994
132. Stremlau A, Gissmann L, Ikenberg H, Stark M, Bannasch P, zur Hausen H: Human papillomavirus type 16 related DNA in an anaplastic carcinoma of the lung. Cancer 55: 1737-1740, 1985
133. Kahn T, Schwarz E, zur Hausen H: Molecular cloning and characterization of the DNA of a new human papillomavirus (HPV 30) from a laryngeal carcinoma. Int J Cancer 37: 61-65, 1986
134. Yousem SA, Ohori NP, Sonmez-Alpan E: Occurrence of human papillomavirus DNA in primary lung neoplasms. Cancer 69: 693-697, 1992
135. Shamanin V, Delius H, de Villiers E-M: Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J Gen Virol 75: 1149-1156, 1994
136. Zur Hausen H, Schneider A: The role of papillomaviruses in human anogenital cancer. In: Salzman NP, Howley PM (eds) The Papovaviridae, Vol. 2. Plenum Press, New York, 1987, pp 245-263
137. Pirisi L, Yasumoto S, Feller M, Doniger J, DiPaolo JA: Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol 61: 1061-1066, 1987
138. Durst M, Dzarlieva-Petrusevska RT, Boukamp P, Fusenig NE, Gissmann L: Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus typo 16 DNA. Oncogene 1: 251-256, 1987
139. Park NH, Min BM, Li SL, Huang MZ, Cherick HM, Doniger J: Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 12: 1627-1631, 1991
140. Band V, Zajchowski D, Kulesa V, Sager R: Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. J Virol 87: 463-467, 1990
141. Kaur P, McDougall JK: Characterization of primary human keratinocytes transformed by human papillomavirus type 18. J Virol 62: 1917-1924, 1988
142. Schlegel R, Phelps WC, Zhang Y-L, Barbosa M: Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J 7: 3181-3187, 1988
143. Pecoraro G, Morgan D, Defendi V: Differential effects of human papillomavirus type 6, 16, and 18 DNAs on immortalization and transformation of human cervical epithelial cells. Proc Natl Acad Sci USA 86: 563-567, 1989
144. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R: The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63: 4417-4421, 1989
145. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT: HPV 16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 8: 3905-3910, 1989
146. Hudson JB, Bedell MA, McCance DJ, Laimins LA: Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J Virol 64: 519-526, 1990
147. Choo K-B, Pan C-C, Han S-H: Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 161: 259-261, 1987
148. Smotkin D, Wettstein FO: Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci USA 83: 4680-4684, 1986
149. Shirasawa H, Tomita Y, Kubota K, Kasai T, Sekiya S, Takamizawa H, Simizu B: Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas. J Virol 62: 1022-1027, 1988
150. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H: Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314: 111-114, 1985
151. Baker CC, Phelps WC, Linderen V, Braun MJ, Gonda MA, Howley PM: Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 61: 962-971, 1987
152. Seedorf K, Oltersdorf T, Krammer G, Rowekamp W: Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells. EMBO J 6: 139-144, 1987
153. Androphy EJ, Hubbert NL, Schiller JT, Lowy DR: Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J 6: 989-992, 1987
154. Smotkin D, Wettstein FO: The major human papillomavirus protein in cervical cancers is a cytoplasmic phospho-protein. J Virol 61: 1686-1689, 1987
155. Dyson N, Howley PM, Munger K, Harlow E: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-937, 1989
156. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM: Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 8: 4099-4105, 1989
157. Riley DJ, Lee EY-HP, Lee W-H: The retinoblastoma protein: more than a tumor suppressor. Annu Rev Cell Biol 10: 1-29, 1994
158. Nevins JR: E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258: 424-429, 1992
159. Arroyo M, Bagchi S, Raychaudhuri P: Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex. Mol Cell Biol 13: 6537-6546, 1993
160. Dyson N, Guida P, Munger K, Harlow E: Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol 66: 6893-6902, 1992
161. CDK2 and cyclin A. Oncogene 8: 195-202, 1993
162. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79, 1990
163. Huibregtse JM, Scheffner M, Howley PM: Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol 13: 4918-1927, 1993
164. Harris CC: p53: At the crossroads of molecular carcinogenesis and risk assessment. Science 262: 1980-1981, 1993
165. Pines J: Arresting developments in cell-cycle control. Trends Biochem Sci 19: 143-145, 1994
166. De Villiers E-M, Schneider A, Miklaw H, Papendick U, Wagner D, Wesch H, Wahrendorf J, zur Hausen H: Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet 2: 703-706, 1987
167. Zur Hausen H: Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet 2: 489-491, 1986
168. Kim MS, Shin K-H, Back J-H, Cherrick HM, Park N-H: HPV-16, tobacco-specific N-Nitrosamine, and N-methyl-N′-nitro-N-nitrosoguanidine in oral carcinogcnesis. Cancer Res 53: 4811-4816, 1993
169. Pecoraro G, Lee M, Morgan D, Defendi V: Evolution of in vitro transformation and tumorigenesis of HPV 16 and HPV 18 immortalized primary cervical epithelial cells. Am J Pathol 138: 1-8, 1990
170. Hurlin PJ, Kaur P, Smith PP, Perez-Reyes N, Blanton RA, McDougall JK: Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype. Proc Natl Acad Sci USA 88: 570-574, 1991
171. Garrett LR, Perez-Reyes N, Smith PP, McDougall JK: Interaction of HPV-18 and nitrosomethylurea in the induction of squamous cell carcinoma. Carcinogenesis 14: 329-332, 1993
172. Klingelhutz AJ, Smith PP, Garrett LR, McDougall JK: Alteration of the DCC tumor-suppressor gene in tumorigenic HPV-18 immortalized human keratinocytes transformed by nitrosomethylurea. Oncogene 8: 95-99, 1993
173. Klingelhutz AJ, Hedrick L, Cho KR, McDougall JK: The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Oncogene 10: 1581-1586, 1995
174. DiPaolo JA, Woodworth CD, Popescu NC, Notario V, Doniger J: Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras. Oncogene 4: 395-399, 1989
175. Riou G, Barrois M, Sheng ZM, Duvillard P, Lhomme C: Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. Oncogene 3: 329-333, 1988
176. DiPaolo JA, Woodworth CD, Popescu NC, Koval DL, Lopez JV, Doniger J: HSV-2-induced tumorigenicity in HPV 16-immortalized human genital keratinocytes. Virology 177: 777-779, 1990
177. Von Knebel Doeberitz M, Rittmuller C, Aengencyndt F, Jansen-Durr P, Spitkovsky D: Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. J Virol 68: 2811-2821, 1994
178. Von Knebel Doeberitz M, Rittmuller C, zur Hausen H, Durst M: Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA. Int J Cancer 51: 831-834, 1992